Kevin Rakin is Director at ORAMED PHARMACEUTICALS INC. (ORMP). They have made 9 open-market trades across 7 companies since 2006, most recently 2026-06-01.
CIK 0001184421
4 open-market purchases totalling $249K since 2007, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HSGX | 418,639 | $4.1M |
| QSI | 1,200,000 | $1.3M |
| ORMP | 46,661 | $189K |
| ELUT | 126,120 | $97K |
| OMRI | 6,000 | — |
| CLDA | 39,826 | — |
| VION | 7,229 | — |
| Total | $5.7M |
Shares reported on the most recent Form 4, priced at the 2026-06-02 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELUT | BUY | 2026-01-30 | 2026-02-02 | $1.06 | $74K | -10.3% | +12.3% | -3.8% |
| QSI | SELL | 2022-12-15 | 2022-12-16 | $2.15 | $191K | -8.1% | +19.7% | -10.6% |
| ORMP | SELL | 2022-03-21 | 2022-03-22 | $9.41 | $94K | -7.4% | -35.5% | -54.6% |
| ORMP | SELL | 2021-09-16 | 2021-09-20 | $20.99 | $886K | +14.0% | +14.7% | -21.6% |
| HSGX | SELL | 2014-12-08 | 2014-12-08 | $11.00 | $187 | -28.6% | -8.7% | -8.7% |
| HSGX | BUY | 2014-12-08 | 2014-12-08 | $11.00 | $124K | -28.6% | -8.7% | -8.7% |
| OMRI | BUY | 2008-03-26 | 2008-03-28 | $13.65 | $27K | N/A | N/A | N/A |
| VION | BUY | 2007-03-13 | 2007-03-15 | $1.59 | $24K | N/A | N/A | N/A |
| CLDA | SELL | 2006-11-20 | 2006-11-27 | $16.18 | $162K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.